Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Apr;33(4):918–923. doi: 10.1128/jcm.33.4.918-923.1995

Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting.

N S Taylor 1, J G Fox 1, N S Akopyants 1, D E Berg 1, N Thompson 1, B Shames 1, L Yan 1, E Fontham 1, F Janney 1, F M Hunter 1
PMCID: PMC228068  PMID: 7790461

Abstract

The gastric pathogen Helicobacter pylori establishes long-term chronic infections that can lead to gastritis, peptic ulcers, and cancer. The species is so diverse that distinctly different strains are generally recovered from each patient. To better understand the dynamics of long-term carriage, we characterized H. pylori isolates from initial and follow-up biopsy specimens from a patient population at high risk of H. pylori infection and gastric cancer. Eighty-five isolates were obtained from 23 patients and were analyzed by genomic restriction enzyme analysis, arbitrarily primed PCR fingerprinting, (random amplified polymorphic DNA analysis), and/or restriction of specific PCR-amplified genes (restriction fragment length polymorphism analysis). A single strain was found in sequential biopsy specimens from 12 of 15 patients (80%) receiving sucralfate. In the remaining three patients treated with sucralfate, two strains were identified in two patients and three strains were identified in the third patient. In contrast, a single strain was found in sequential biopsy specimens from only three of eight patients (37%) receiving bismuth, metronidazole, and nitrofurantoin. Two strains were identified in five other patients receiving bismuth-antibiotic (63%). Immunoglobulin G antibodies to H. pylori were present in the sera of all patients. Thus, H. pylori colonization can persist for long periods (up to at least 4 years), despite high titers of immunoglobulin G antibodies in serum. Resistance to metronidazole was noted in some strains before and/or after treatment, but all strains remained susceptible to amoxicillin, tetracycline, and nitrofurantoin.(ABSTRACT TRUNCATED AT 250 WORDS)

Full Text

The Full Text of this article is available as a PDF (343.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akopyants N. S., Eaton K. A., Berg D. E. Adaptive mutation and cocolonization during Helicobacter pylori infection of gnotobiotic piglets. Infect Immun. 1995 Jan;63(1):116–121. doi: 10.1128/iai.63.1.116-121.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Akopyanz N., Bukanov N. O., Westblom T. U., Berg D. E. PCR-based RFLP analysis of DNA sequence diversity in the gastric pathogen Helicobacter pylori. Nucleic Acids Res. 1992 Dec 11;20(23):6221–6225. doi: 10.1093/nar/20.23.6221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Akopyanz N., Bukanov N. O., Westblom T. U., Kresovich S., Berg D. E. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res. 1992 Oct 11;20(19):5137–5142. doi: 10.1093/nar/20.19.5137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blaser M. J. Helicobacter pylori: its role in disease. Clin Infect Dis. 1992 Sep;15(3):386–391. doi: 10.1093/clind/15.3.386. [DOI] [PubMed] [Google Scholar]
  5. Borén T., Falk P., Roth K. A., Larson G., Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science. 1993 Dec 17;262(5141):1892–1895. doi: 10.1126/science.8018146. [DOI] [PubMed] [Google Scholar]
  6. Brikun I., Suziedelis K., Berg D. E. DNA sequence divergence among derivatives of Escherichia coli K-12 detected by arbitrary primer PCR (random amplified polymorphic DNA) fingerprinting. J Bacteriol. 1994 Mar;176(6):1673–1682. doi: 10.1128/jb.176.6.1673-1682.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clayton C. L., Kleanthous H., Morgan D. D., Puckey L., Tabaqchali S. Rapid fingerprinting of Helicobacter pylori by polymerase chain reaction and restriction fragment length polymorphism analysis. J Clin Microbiol. 1993 Jun;31(6):1420–1425. doi: 10.1128/jcm.31.6.1420-1425.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cover T. L., Dooley C. P., Blaser M. J. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun. 1990 Mar;58(3):603–610. doi: 10.1128/iai.58.3.603-610.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Evans D. G., Evans D. J., Jr, Moulds J. J., Graham D. Y. N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun. 1988 Nov;56(11):2896–2906. doi: 10.1128/iai.56.11.2896-2906.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Figura N., Guglielmetti P., Rossolini A., Barberi A., Cusi G., Musmanno R. A., Russi M., Quaranta S. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol. 1989 Jan;27(1):225–226. doi: 10.1128/jcm.27.1.225-226.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fox J. G., Correa P., Taylor N. S., Thompson N., Fontham E., Janney F., Sobhan M., Ruiz B., Hunter F. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol. 1992 Nov;87(11):1554–1560. [PubMed] [Google Scholar]
  12. Fox J. G., Correa P., Taylor N. S., Zavala D., Fontham E., Janney F., Rodriguez E., Hunter F., Diavolitsis S. Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol. 1989 Jul;84(7):775–781. [PubMed] [Google Scholar]
  13. Foxall P. A., Hu L. T., Mobley H. L. Use of polymerase chain reaction-amplified Helicobacter pylori urease structural genes for differentiation of isolates. J Clin Microbiol. 1992 Mar;30(3):739–741. doi: 10.1128/jcm.30.3.739-741.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fujimoto S., Marshall B., Blaser M. J. PCR-based restriction fragment length polymorphism typing of Helicobacter pylori. J Clin Microbiol. 1994 Feb;32(2):331–334. doi: 10.1128/jcm.32.2.331-334.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Glupczynski Y., Delmee M., Bruck C., Labbe M., Avesani V., Burette A. Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents. Eur J Epidemiol. 1988 Jun;4(2):154–157. doi: 10.1007/BF00144743. [DOI] [PubMed] [Google Scholar]
  16. Goodwin C. S., Blake P., Blincow E. The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. J Antimicrob Chemother. 1986 Mar;17(3):309–314. doi: 10.1093/jac/17.3.309. [DOI] [PubMed] [Google Scholar]
  17. Hirschl A. M., Richter M., Makristathis A., Prückl P. M., Willinger B., Schütze K., Rotter M. L. Single and multiple strain colonization in patients with Helicobacter pylori-associated gastritis: detection by macrorestriction DNA analysis. J Infect Dis. 1994 Aug;170(2):473–475. doi: 10.1093/infdis/170.2.473. [DOI] [PubMed] [Google Scholar]
  18. Lingwood C. A., Law H., Pellizzari A., Sherman P., Drumm B. Gastric glycerolipid as a receptor for Campylobacter pylori. Lancet. 1989 Jul 29;2(8657):238–241. doi: 10.1016/s0140-6736(89)90428-5. [DOI] [PubMed] [Google Scholar]
  19. McNulty C. A., Dent J. C. Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents. Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):566–569. doi: 10.1007/BF01962617. [DOI] [PubMed] [Google Scholar]
  20. Morgan D., Kraft W., Bender M., Pearson A. Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. The Gastrointestinal Physiology Working Group of Cayetano Heredia and The Johns Hopkins Universities. Gastroenterology. 1988 Nov;95(5):1178–1184. doi: 10.1016/0016-5085(88)90348-4. [DOI] [PubMed] [Google Scholar]
  21. Morris A. J., Ali M. R., Nicholson G. I., Perez-Perez G. I., Blaser M. J. Long-term follow-up of voluntary ingestion of Helicobacter pylori. Ann Intern Med. 1991 Apr 15;114(8):662–663. doi: 10.7326/0003-4819-114-8-662. [DOI] [PubMed] [Google Scholar]
  22. Nomura A., Stemmermann G. N. Helicobacter pylori and gastric cancer. J Gastroenterol Hepatol. 1993 May-Jun;8(3):294–303. doi: 10.1111/j.1440-1746.1993.tb01202.x. [DOI] [PubMed] [Google Scholar]
  23. Otto G., Fox J. G., Wu P. Y., Taylor N. S. Eradication of Helicobacter mustelae from the ferret stomach: an animal model of Helicobacter (Campylobacter) pylori chemotherapy. Antimicrob Agents Chemother. 1990 Jun;34(6):1232–1236. doi: 10.1128/aac.34.6.1232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Oudbier J. H., Langenberg W., Rauws E. A., Bruin-Mosch C. Genotypical variation of Campylobacter pylori from gastric mucosa. J Clin Microbiol. 1990 Mar;28(3):559–565. doi: 10.1128/jcm.28.3.559-565.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Owen R. J., Bickley J., Costas M., Morgan D. R. Genomic variation in Helicobacter pylori: application to identification of strains. Scand J Gastroenterol Suppl. 1991;181:43–50. doi: 10.3109/00365529109093207. [DOI] [PubMed] [Google Scholar]
  26. Owen R. J., Desai M., Figura N., Bayeli P. F., Di Gregorio L., Russi M., Musmanno R. A. Comparisons between degree of histological gastritis and DNA fingerprints, cytotoxicity and adhesivity of Helicobacter pylori from different gastric sites. Eur J Epidemiol. 1993 May;9(3):315–321. doi: 10.1007/BF00146270. [DOI] [PubMed] [Google Scholar]
  27. Pavicić M. J., Namavar F., Verboom T., van Winkelhoff A. J., De Graaff J. In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations. Antimicrob Agents Chemother. 1993 May;37(5):1184–1186. doi: 10.1128/aac.37.5.1184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Prewett E. J., Bickley J., Owen R. J., Pounder R. E. DNA patterns of Helicobacter pylori isolated from gastric antrum, body, and duodenum. Gastroenterology. 1992 Mar;102(3):829–833. doi: 10.1016/0016-5085(92)90165-u. [DOI] [PubMed] [Google Scholar]
  29. Rautelin H., Seppälä K., Renkonen O. V., Vainio U., Kosunen T. U. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother. 1992 Jan;36(1):163–166. doi: 10.1128/aac.36.1.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rautelin H., Tee W., Seppälä K., Kosunen T. U. Ribotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori. J Clin Microbiol. 1994 Apr;32(4):1079–1082. doi: 10.1128/jcm.32.4.1079-1082.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Simor A. E., Shames B., Drumm B., Sherman P., Low D. E., Penner J. L. Typing of Campylobacter pylori by bacterial DNA restriction endonuclease analysis and determination of plasmid profile. J Clin Microbiol. 1990 Jan;28(1):83–86. doi: 10.1128/jcm.28.1.83-86.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sipponen P. Gastric cancer--a long-term consequence of Helicobacter pylori infection? Scand J Gastroenterol Suppl. 1994;201:24–27. [PubMed] [Google Scholar]
  33. Taylor N. S., Hasubski A. T., Fox J. G., Lee A. Haemagglutination profiles of Helicobacter species that cause gastritis in man and animals. J Med Microbiol. 1992 Nov;37(5):299–303. doi: 10.1099/00222615-37-5-299. [DOI] [PubMed] [Google Scholar]
  34. Tee W., Lambert J., Smallwood R., Schembri M., Ross B. C., Dwyer B. Ribotyping of Helicobacter pylori from clinical specimens. J Clin Microbiol. 1992 Jun;30(6):1562–1567. doi: 10.1128/jcm.30.6.1562-1567.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. van Zwet A. A., Thijs J. C., Schievink-de Vries W., Schiphuis J., Snijder J. A. In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori. Antimicrob Agents Chemother. 1994 Feb;38(2):360–362. doi: 10.1128/aac.38.2.360. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES